• Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility
  • Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility
  • Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility
  • Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility
  • Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility
Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility Alexion Pharmaceuticals, Biopharmaceutical Manufacturing Facility

Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc., the nation’s fifth fastest-growing pharmaceutical company, sought Dacon’s expertise during the planning phase for a 20,800 SF office and laboratory addition to its existing 60,000 SF manufacturing site in Smithfield, Rhode Island. With a goal of creating a stronger corporate image, Dacon defined the project and established the overall program and design, working within existing site restraints and building limitations. Following the planning phase, Alexion awarded Dacon the contract to proceed with construction. The project entailed the addition of research and development (R&D) laboratories, as well as quality assurance (QA) laboratories. Dacon managed all aspects of construction, including planning, design, zoning approvals, code compliance, engineering and construction. Key to the project’s success was Dacon’s ability to complete the work without interruption to Alexion’s operations, as the Smithfield site is their only manufacturing site. With the addition complete, Alexion chose to continue its relationship with Dacon by awarding them the contract to design and build a new, 5,000 SF cafeteria on site.